BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 237 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $152,967 | +43.5% | 24,752 | +18.0% | 0.00% | +33.3% |
| Q1 2024 | $106,568 | -15.2% | 20,978 | 0.0% | 0.00% | -25.0% |
| Q4 2023 | $125,658 | -15.4% | 20,978 | 0.0% | 0.00% | -33.3% |
| Q3 2023 | $148,524 | +11.2% | 20,978 | +10.6% | 0.01% | +20.0% |
| Q2 2023 | $133,576 | -15.6% | 18,974 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $158,243 | +71503.2% | 18,974 | -1.4% | 0.01% | -33.3% |
| Q4 2022 | $221 | -99.9% | 19,237 | -1.4% | 0.01% | -18.2% |
| Q3 2022 | $246,000 | +20.0% | 19,515 | +0.6% | 0.01% | +22.2% |
| Q2 2022 | $205,000 | -30.7% | 19,408 | +6.6% | 0.01% | -10.0% |
| Q1 2022 | $296,000 | +17.5% | 18,208 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $252,000 | – | 18,208 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |